Daily iron supplementation significantly improves maximal and submaximal exercise performance in WRA , providing a rationale to prevent and treat iron deficiency in this group .
Animal and human observational studies suggest that iron deficiency impairs physical exercise performance , but findings from r and omized trials on the effects of iron are equivocal .
Iron deficiency and anemia are especially common in women of reproductive age ( WRA ) .
Clear evidence of benefit from iron supplementation would inform clinical and public health guidelines .
Therefore , we performed a systematic review and meta- analysis to determine the effect of iron supplementation compared with control on exercise performance in WRA .
Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors: a randomized controlled trial
Background Iron deficiency without anemia is related to adverse symptoms that can be relieved by supplementation . Since a blood donation can induce such an iron deficiency , we investigated the clinical impact of iron treatment after a blood donation . Methods One week after donation , we r and omly assigned 154 female donors with iron deficiency without anemia , aged below 50 years , to a four-week oral treatment of ferrous sulfate versus a placebo . The main outcome was the change in the level of fatigue before and after the intervention . Aerobic capacity , mood disorder , quality of life , compliance and adverse events were also evaluated . Hemoglobin and ferritin were used as biological markers . Results The effect of the treatment from baseline to four weeks of iron treatment was an increase in hemoglobin and ferritin levels to 5.2 g/L ( P < 0.01 ) and 14.8 ng/mL ( P < 0.01 ) , respectively . No significant clinical effect was observed for fatigue ( -0.15 points , 95 % confidence interval -0.9 points to 0.6 points , P = 0.697 ) or for other outcomes . Compliance and interruption for side effects was similar in both groups . Additionally , blood donation did not induce overt symptoms of fatigue in spite of the significant biological changes it produces . Conclusions These data are valuable as they enable us to conclude that donors with iron deficiency without anemia after a blood donation would not clinical ly benefit from iron supplementation . Trial Registration Clinical Trials.gov :
Daily iron supplementation significantly improves maximal and submaximal exercise performance in WRA , providing a rationale to prevent and treat iron deficiency in this group .
Animal and human observational studies suggest that iron deficiency impairs physical exercise performance , but findings from r and omized trials on the effects of iron are equivocal .
Iron deficiency and anemia are especially common in women of reproductive age ( WRA ) .
Clear evidence of benefit from iron supplementation would inform clinical and public health guidelines .
Therefore , we performed a systematic review and meta- analysis to determine the effect of iron supplementation compared with control on exercise performance in WRA .